Role of phaltrikadi kwath in Diabetic dislipidemia
Phase 2
- Conditions
- Health Condition 1: E781- Pure hyperglyceridemia
- Registration Number
- CTRI/2023/10/058859
- Lead Sponsor
- Dr Mahesh H Pandey
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Pre diagnosed patients Type 2 diabetes mellitus patient who are already on any type of oral hypoglycemic agent
2)Patients with HbA1c value more than 6.5%
3)Age group – 18 to 80 years
4)Patients of either Gender
5)Triglyceride levels > 150 mg/dl and < 350mg/dl
6)LDL levels >100mg/dl and <200mg/dl
HDL < 40mg/dl
Exclusion Criteria
1)Insulin dependent Diabetes mellitus
2)Any major systemic diseases like Carcinoma, Tuberculosis etc.
3)K/C/O- Neuropathic ulcer, Peripheral Vascular disease.
4)K/C/O Immunosuppressed patients on immunosuppressive drugs.
5)Malignancy disease.
6)Patient on steroid therapy.
7)Pregnant & Lactating women
8)Unable to provide written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary end point <br/ ><br>Decrease in Triglyceride levels <br/ ><br>Timepoint: lipid profile will be done on1st day ,60th day,75th,135th day <br/ ><br>
- Secondary Outcome Measures
Name Time Method Secondary end point <br/ ><br>Effective control of glycaemic Index <br/ ><br> <br/ ><br>Timepoint: blood sugar levels will be done on 1st day 60th day, 75th day and 135th day <br/ ><br>HbA1c will be done on 1st day and 90th day